Vascular Access Procedures Market Size, Share & Trends Analysis Report, By Procedure (Arteriovenous Fistulas, Arteriovenous Grafts, Central Venous Catheters), By Application, By Region, And Segment Forecasts, 2025 - 2030

Vascular Access Procedures Market Trends

The global vascular access procedures market size was estimated at USD 90.7 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2030. Vascular access procedures are used to enter the bloodstream for treatments like medication, fluids, or dialysis. The increasing incidence of chronic diseases is one of the major factors boosting market growth.

According to the Department of Biotechnology article published in February 2025, chronic diseases account for around 73% of deaths globally every year, reflecting a significant shift in the global health landscape toward long-term, non-communicable conditions. This growing burden has intensified the demand for consistent and reliable medical interventions that support ongoing treatment. Vascular access procedures have become critical in managing these conditions, enabling the safe and repeated administration of chemotherapy, hemodialysis, and intravenous medications. The healthcare systems increasingly focus on managing chronic illnesses over extended periods, and the importance of efficient vascular access solutions continues to grow, driving market growth.

Increased cancer cases drive the market growth. According to the WHO article published in February 2024, Cancer remains a leading global health burden, with an estimated 1 in 5 people likely to develop the disease during their lifetime. Mortality rates are also significant, with about 1 in 9 men and 1 in 12 women expected to die from cancer-related causes. Projections indicate a steep rise in new cases, reaching approximately 35 million by 2050, up nearly 77% from the estimated 20 million in 2022. This sharp increase underscores the urgent need for efficient treatment delivery, particularly vascular access procedures, critical for administering chemotherapy and other intravenous therapies. The cancer incidence continues to grow, especially among aging populations, and in low- to middle-income countries, the demand for dependable vascular access will be crucial to ensuring timely and continuous care, thereby driving strong market growth.

Increasing use of vascular access devices for pediatric patients drives the market's growth. According to an NCBI article published in October 2024, a long-term study spanning 4.5 years in two university-affiliated Pediatric Intensive Care Units (PICUs) examined 220 pediatric patients. It revealed significant dependence on vascular access devices, with a total of 683 devices utilized. Half of the patients required three or more devices during their treatment, and over half (54%) experienced at least one complication related to vascular access. This high usage rate and associated complication frequency reflect the critical role of vascular access procedures in managing seriously ill pediatric populations. The data highlights a growing demand for advanced, safer, and more efficient vascular access solutions, further driving the market growth.

Technological advancements in vascular access procedures drive the market growth. According to the Cornell University article published in October 2024, the Micro Smart Tissue Autonomous Robot (micro-STAR), a technologically advanced surgical robot that autonomously performs vascular anastomosis, particularly on small-diameter blood vessels. This device is equipped with Optical Coherence Tomography (OCT) and a microcamera, allowing it to navigate and complete sutures safely. In ex vivo studies, micro-STAR demonstrated outcomes on par with those of experienced surgeons, completing 90% of sutures without human intervention. This advancement is particularly valuable in surgeries requiring the reconnection of small vessels, such as in coronary artery bypass grafting (CABG) and dialysis access surgery for patients with end-stage renal disease.

Moreover, in April 2025, another promising development is integrating a 6-degrees-of-freedom (DoF) robotic arm combined with a 3-DoF end-effector, which utilizes ultrasound guidance to perform precise needle insertion into small-diameter veins and arteries. In in vivo studies on rats, this robotic system achieved a 95% first-attempt success rate, showcasing its ability to navigate difficult vascular access points, particularly in pediatric and geriatric patients who often have more fragile and challenging venous anatomy. This system holds potential for treating conditions like vascular malformations, deep vein thrombosis, and chemotherapy-related venous access, where accurate and minimally invasive access is critical. Thus, these advancements drive the market growth.

Market Concentration & Characteristics

The market is witnessing high innovation, with advancements such as autonomous robotic systems, AI-assisted imaging, and precision-guided catheter technologies. Innovations such as micro-robotic platforms for vascular anastomosis and ultrasound-guided robotic arms for needle insertion enhance procedural accuracy and reduce complications. These advancements are particularly impactful in challenging patient populations, including pediatric, geriatric, and oncology patients, where reliable and minimally invasive access is critical for therapies such as chemotherapy, dialysis, and intravenous antibiotics.

Several market players, such as Teleflex Medical, BD, and B. Braun, are involved in merger and acquisition activities. Through mergers and acquisitions, companies strategically focus on advancing innovation, establishing collaborative alliances, and extending their geographic reach. These initiatives help enhance their competitive standing while addressing the growing need for safer, more effective, and minimally invasive vascular access techniques in critical treatments such as dialysis, chemotherapy, and prolonged intravenous therapy.

Regulatory frameworks are crucial in shaping the vascular access procedures industry. Strict guidelines from agencies like the FDA and EMA ensure device safety and performance, often extending approval timelines. However, initiatives such as expedited review pathways and innovation-friendly policies enable faster market entry for advanced vascular access technologies, including robotic-assisted and infection-resistant devices.

There are no direct substitutes for vascular access procedures, as they are essential for delivering medications, nutrition, and therapies like dialysis and chemotherapy. While alternatives like oral or subcutaneous routes exist, they lack the precision, efficiency, and suitability for long-term or high-volume treatments that vascular access devices provide.

Key players in the vascular access procedures industry are expanding their footprint by increasing procedural training for healthcare providers, collaborating with regional healthcare systems, and adapting procedural approaches to meet local clinical and patient needs in underserved markets.

Procedure Insights

The arteriovenous fistulas segment led the market with the largest revenue share of 71.9% in 2024. The increasing incidence of chronic diseases, rising end-stage renal disease (ESRD) cases, and technological advancements drive segment growth. According to the Journal of Vascular Surgery article published in February 2024, the adoption of arteriovenous fistulas (AVFs) for hemodialysis access remains a key focus in improving patient outcomes, with national initiatives such as the "Fistula First Catheter Last" (FFCL) program aiming to enhance AVF placement rates. Despite challenges in increasing forearm AVF rates, data from 2012 to 2022 show that 57.9% of all hemodialysis accesses were upper arm AVFs, while 25.2% were forearm AVFs, reflecting the ongoing preference for AVFs over arteriovenous grafts (AVGs). Though there was no significant increase in the overall rate of forearm AVFs during this period, a notable rise in upper arm AVGs was observed, especially among elderly and female patients, suggesting an evolving landscape in access procedures.

The arteriovenous grafts segment is expected to grow at the fastest CAGR during the forecast period, owing to the growing adoption of arteriovenous grafts (AVGs) in dialysis access and technological advancements, which drive the development of the market. According to the Elsevier B.V. article published in February 2025, a recent study examining the impact of antiplatelet and anticoagulation therapies on outcomes following dialysis access creation revealed positive results for AVG patients using single antiplatelet therapy (SAPT). Specifically, AVG patients on SAPT demonstrated improved 1-year primary patency (48% vs. 44%) and a decreased risk of mortality hazard ratio (HR 0.80). In addition, dual antiplatelet therapy (DAPT) showed even better outcomes, with a reduced risk of primary patency loss (HR 0.64). This evidence emphasizes the increasing efficacy and adoption of AVGs, particularly when supported by optimal pharmacological management. Such developments improve patient survival and enhance AVG procedures' overall success rates, fostering the market growth.

Application Insights

The hemodialysis segment led the market with the largest revenue share of 53.4% in 2024, due to the increasing incidence of chronic diseases, rising procedures of hemodialysis, and technological advancements. According to the Paras Health article published in February 2025, an estimated 2.5 million individuals currently depend on the treatment, projections indicating this figure may double within the next 10 years. This escalating demand for dialysis is directly linked to a greater need for reliable vascular access, especially for hemodialysis, which requires consistent and efficient blood flow through access points like arteriovenous fistulas, grafts, or central venous catheters. The growing patient base significantly contributes to the increased volume of vascular access procedures, making hemodialysis one of the most prominent and expanding application segments in the market.

The intravenous antibiotics treatment segment is anticipated to grow at the fastest CAGR during the forecast period, owing to increased use of Intravenous Antibiotics Treatment and technological advancements, which drive the market's growth. According to the MDPI article published in January 2025, a multinational cohort study involving 668 patients with early post-operative PJIs treated with debridement, antibiotics, and implant retention (DAIR) revealed insights into the effectiveness of IV antibiotic therapy. A study examining different durations of IV antibiotic therapy showed that the failure rates were relatively similar across short (<14 days), intermediate (14-27 days), and long (>27 days) IV treatment durations, with failure rates of 41.5%, 44.4%, and 42.1%, respectively. Despite these comparable outcomes, longer durations of IV therapy (≥14 days) have been found to provide added benefits for patients with high pre-operative serum C-reactive protein levels or inadequate debridement during the debridement, antibiotics, and implant retention (DAIR) procedure. This highlights the continued reliance on extended IV antibiotic treatment for managing complex infections, driving the demand for reliable vascular access solutions to support these prolonged therapies.

Regional Insights

North America dominated the vascular access procedures market with the largest revenue share of 39.5% in 2024, due to the rising chronic incidence, such as CKD (Chronic Kidney Diseases), increasing use of vascular access devices for pediatric patients, and technological advancements, drive the demand for vascular access procedures in North America. According to an American Kidney Fund, Inc. article published in February 2025, reliable vascular access solutions are more critical than ever with an estimated 35.5 million Americans affected by kidney disease. Approximately 815,000 Americans are living with kidney failure, and nearly 555,000 of them rely on dialysis for treatment. These high numbers underscore the importance of effective vascular access procedures, such as arteriovenous fistulas, arteriovenous grafts, and central venous catheters, which are essential for facilitating dialysis. As the patient population continues to rise, the demand for advanced vascular access technologies and services is expected to grow, further expanding the market in North America.

U.S. Vascular Access Procedures Market Trends

The vascular access procedures market in the U.S. accounted for the largest market revenue share of North America in 2024. Increasing cancer incidence and technological advancements drive the growth of the market. According to the John Wiley & Sons, Inc. article published in January 2025, the U.S. is projected to see approximately 2,041,910 new cancer diagnoses, equating to roughly 5,600 new cases daily. This increasing cancer incidence directly influences the demand for vascular access procedures, as many cancer patients require reliable and effective vascular access solutions, particularly for treatments like chemotherapy. Central venous catheters and other vascular access devices are essential for administering chemotherapy, contributing to the growing need for advanced vascular access technologies in the U.S. market. The rising cancer diagnosis rates underscore the critical role of vascular access procedures in supporting the treatment of a significant number of patients in the U.S. healthcare system.

Europe Vascular Access Procedures Market Trends

The vascular access procedures market in the Europe accounted for the second-largest market revenue share in 2024. Increased chronic diseases, cancer cases, and technological advancements drive the market's growth. According to the BioMed Central Ltd article published in March 2025, Europe reported over 4.47 million new cancer cases in 2022, with an age-standardized rate of 280 per 100,000 individuals and a cumulative risk of developing cancer by the age of 75. This significantly contributes to the rising demand for vascular access across the region. Many cancer patients require long-term vascular access for chemotherapy and supportive treatments, making devices like central venous catheters and implanted ports essential components of cancer care. The cancer incidence continues to rise in Europe, and the need for safe, efficient, and durable vascular access solutions is expected to drive growth in the vascular access procedures market.

The Germany vascular access procedures market accounted for the largest market revenue share of 33.1% in 2024. Increasing incidence of chronic diseases, cancer, and technological advancements drive the market's growth. According to the OECD article published in November 2024, cancer remains a significant health burden in Germany, ranking as the second leading cause of mortality in the country. Projections indicate that between 2023 and 2050, approximately 26% of premature deaths-those occurring before the age of 75 will be attributed to cancer, equating to an estimated 65,100 premature cancer-related deaths annually. The widespread impact of cancer is also expected to lower the national average life expectancy by around two years in the absence of effective interventions. Given the growing cancer burden, the demand for vascular access procedures is expected to rise in tandem. These procedures are essential for facilitating the safe and efficient delivery of intravenous therapies such as chemotherapy, making them a critical component of oncology care in Germany’s healthcare infrastructure.

The vascular access procedures market in the UK accounted for the second-largest market share in 2024. The rising cancer cases in the UK are fueling the market's growth. According to a Macmillan Cancer Support article in February 2025, there are an estimated 3.5 million individuals currently living with the disease in the UK. On average, someone is diagnosed with cancer every 90 seconds, underscoring the persistent and widespread nature of the condition. In addition, cancer accounts for approximately 167,000 deaths annually, averaging around 460 fatalities per day. This high disease burden amplifies the need for effective and reliable vascular access procedures, which are vital for the administration of chemotherapy and other cancer-related intravenous treatments.

The France vascular access procedures market is anticipated to witness at a significant CAGR of 5.9% during the forecast period. The increasing incidence of chronic diseases, including cancer, and technological advances drive the market's growth. According to the OECD article published in February 2025, in France, cancer remains one of the most significant public health challenges, accounting for approximately one in every four deaths nationwide. This high mortality rate underscores the substantial burden cancer imposes on the healthcare system, particularly in terms of long-term treatment requirements such as chemotherapy. Many cancer patients rely on sustained intravenous therapy, and the demand for reliable and efficient vascular access procedures has increased significantly. This growing need is fueling the expansion of France's vascular access procedures market, as hospitals and oncology centers seek advanced solutions to improve patient outcomes and treatment continuity.

Asia Pacific Vascular Access Procedures Market Trends

The vascular access procedures market in the Asia Pacific is expected to grow at the fastest CAGR during the forecast period. The rising chronic disease cases, increasing cancer cases, and technological advancements drive the market's growth. According to the WHO article published in September 2024, approximately 2.37 million new cancer cases and 1.53 million cancer-related deaths were reported in 2022. This already significant burden is expected to grow sharply, with new cancer cases projected to rise by 85.7% by 2050. This anticipated surge highlights a critical need for scalable, efficient, and safe vascular access solutions across the Asia-Pacific (APAC) region. Cancer treatments such as chemotherapy require repeated and prolonged intravenous access; the growing patient pool is driving the demand for vascular access procedures. Healthcare systems throughout APAC are increasingly prioritizing investments in vascular access technologies to support oncology care, thereby propelling the regional market’s growth.

The China vascular access procedures market accounted for the largest market revenue share in the Asia Pacific in 2024. Increasing cancer cases and technological advancements drive the market growth. According to the NCBI article published in December 2024, China is projected to record approximately 3,246,625 million new cancer cases and over 1,699,066 million cancer-related deaths in 2024. This immense burden underlines the escalating demand for adequate treatment infrastructure, particularly vascular access procedures that are critical for chemotherapy administration and other intravenous therapies. The rising incidence of cancer in China is significantly contributing to the need for reliable and durable vascular access devices, such as central venous catheters and implantable ports. As the country continues to invest in expanding its oncology services, the vascular access procedures market is poised to experience robust growth, driven by the growing patient base requiring long-term IV treatment and supportive care.

The vascular access procedures market in Japan is anticipated to grow at a significant CAGR during the forecast period. Increasing hemodialysis cases, cancer incidence, and technological advancements drive the market's growth. According to a BioMed Central Ltd article published in January 2025, with an estimated 347,671 individuals undergoing dialysis treatment, there is a consistent and growing demand for vascular access interventions essential for hemodialysis delivery. The financial burden associated with outpatient maintenance dialysis is substantial, amounting to approximately 1.46 trillion Japanese Yen (around 13.9 billion USD) annually. This high expenditure underscores the critical role of reliable and efficient vascular access in ensuring the continuity and effectiveness of dialysis care. As a result, there is an ongoing need for advanced vascular access devices and techniques, which is expected to drive innovation and growth within the market.

The India vascular access procedures market is anticipated to experience at a significant CAGR during the forecast period, driven by the increasing number of cancer cases in India and technological advancements. According to the Indian Council of Medical Research (ICMR) article published in February 2025, over 1.4 million new cancer cases were reported in 2023 alone. With approximately 100 individuals per 100,000 population diagnosed with cancer, the need for reliable vascular access, which is crucial for administering chemotherapy and other intravenous treatments, has become more critical. This growing patient population is likely to contribute to expanding the vascular access procedures market, driving demand for both short-term and long-term vascular access devices in oncology care.

Latin America Vascular Access Procedures Market Trends

The vascular access procedures market in Latin America is growing due to several factors. Rising cancer cases and technological advancements drive the market growth. According to the NCBI article published in January 2025, Latin America recorded approximately 1.5 million new cancer cases and around 750,000 cancer-related deaths in 2022. This high incidence and mortality underscore the urgent need for effective cancer management, including the delivery of chemotherapy and supportive therapies, which heavily rely on vascular access devices.

The Brazil vascular access procedures market is expanding due to several distinct growth drivers. The growing dialysis population and technological advancements drive the market growth. According to the Brazilian Dialysis Survey, as of July 2023, an estimated 157,357 individuals were receiving dialysis treatment in Brazil, with 51,153 new patients initiating dialysis that same year. These figures highlight the increasing demand for vascular access solutions essential for enabling regular hemodialysis. The continued rise in kidney disease prevalence and new dialysis cases is expected to drive sustained demand for vascular access devices and procedures, making this a key segment in Brazil’s broader healthcare landscape.

Middle East & Africa Vascular Access Procedures Market Trends

The vascular access procedures market in the Middle East & Africa is expected to grow at a lucrative CAGR during the forecast period, due to the rising incidences of chronic diseases such as kidney failure and cancer. With the region's growing population and an expanding healthcare infrastructure, the demand for reliable vascular access devices and procedures is rising. In particular, the rising number of patients undergoing dialysis and the need for oncology treatments like chemotherapy fuel this market's expansion.

The Saudi Arabia vascular access procedures market is expected to grow at a substantial CAGR of 4.2% over the forecast period. The increasing incidence of dialysis procedures and technological advancements drive the market's growth. According to the Elsevier B.V. article published in March 2025, with an estimated prevalence of 294 cases per million people, more than 20,000 patients are currently undergoing dialysis in the country. This high number of dialysis patients highlights the critical need for effective vascular access solutions, as these procedures are essential for ensuring consistent and reliable treatment for individuals with chronic kidney failure. As the prevalence of kidney disease continues to rise in Saudi Arabia, the market for vascular access devices and related procedures is expected to expand, prompting further advancements in medical technologies to meet the growing healthcare demands. 

Key Vascular Access Procedures Company Insights

Some of the key players operating in the industry include Teleflex Medical, BD, and B. Braun. The company’s key strategies include understanding the strengths and weaknesses of major market participants, anticipating future market trends, opportunities, and challenges, and making proactive decisions based on insights into emerging technologies and changing consumer preferences. For instance, Access Vascular, Inc. and Angio Dynamics are some of the emerging players in vascular access procedures industry.

Recent Developments

• In October 2024, BD, a key player in medical technologies, launched the BD Intraosseous Vascular Access System, a ground-breaking solution for emergency care. This system enables quick access to the bloodstream to administer fluids and medications, especially when traditional intravenous (IV) access is difficult or impossible. Inserting a needle directly into the bone marrow cavity provides a crucial alternative for patients in urgent need of treatment, ensuring timely and effective care in critical situations.

• In May 2024, Teleflex, a key player in medical technology and a trailblazer in intraosseous vascular access, unveiled the Arrow EZ-IO Intraosseous Access Procedure Tray. This single-use, sterile tray is equipped with all the essential tools for conducting the IO access procedure, aiming to streamline the process and improve efficiency for medical practitioners.

• In October 2023, B. Braun Medical Inc., a leading innovator in infusion therapy, introduced the Introcan Safety 2 IV Catheter with Multi-Access Blood Control. This advanced catheter builds on B. Braun's commitment to improving safety with passive needlestick prevention. Featuring an automatic needlestick protection mechanism, it also includes a blood control system that prevents exposure to blood each time the hub is accessed, lowering the risk of bloodborne pathogen transmission throughout the intravenous process.

Vascular Access Procedures Market Report Scope

Global Vascular Access Procedures Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and analyzes the industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global vascular access procedures market report based on procedure type, application, and region:

• Procedure Outlook (Revenue, USD Billion, 2018 - 2030)

  • Arteriovenous Fistulas

  • Arteriovenous Grafts

  • Central Venous Catheters

  • Others

• Application Outlook (Revenue, USD Billion, 2018 - 2030)

  • Chemotherapy

  • Hemodialysis

  • Blood Transfusions

  • Intravenous Antibiotics Treatment

  • Others  

• Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait